Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma major posted a ...
Brokerages Citi and Jefferies maintain "Buy" ratings on Indus Towers, Nippon Life India Asset Management, and UltraTech Cement, citing strong growth potential, cost efficiencies, and improved ...
Dr. Reddy's Laboratories shares in Friday's trade slipped by over 6 per cent in early trade to the day's low price of Rs 1,203.6 after the pharma major posted weak performance during the December ...
Apple Inc (NASDAQ:AAPL)., with its impressive $3.36 trillion market capitalization, is navigating a complex landscape of opportunities and challenges as it enters 2025. As a prominent player in the ...
Bharat Dynamics, Bajaj Finserv and Karur Vysya Bank are among top stocks to buy recommendations today for intraday. Besides, brokerages have recommended BPCL, UltraTech Cement, Dr Reddy's, United ...